Characteristics of Long-Term Survivors of Epithelial Ovarian Cancer
- PMID: 26244529
- PMCID: PMC4545401
- DOI: 10.1097/AOG.0000000000000981
Characteristics of Long-Term Survivors of Epithelial Ovarian Cancer
Abstract
Objective: To identify characteristics associated with long-term survival for patients with epithelial ovarian cancer using the California Cancer Registry.
Methods: A descriptive analysis of survival of all California residents diagnosed with epithelial ovarian cancer between 1994 and 2001 was conducted using patients identified through the cancer registry with follow-up through 2011. Characteristics of the patients who survived more than 10 years (long-term survivors) were compared with three other cohorts: patients who survived less than 2 years, those who survived at least 2 but no more than 5 years, and those who survived at least 5 but no more than 10 years.
Results: A total of 3,582 out of 11,541 (31%, confidence interval 30.2-31.8%) of the patients survived more than 10 years. Younger age, early stage, low-grade, and nonserous histology were significant predictors of long-term survival, but long-term survivors also included women with high-risk cancer.
Conclusion: Long-term survival is not unusual in patients with epithelial ovarian cancer, even in those with high-risk disease. Many of the prognostic factors are well known, but it remains to be determined why some patients with advanced-stage high-grade cancers survive longer than others with the same histology. These findings are important for patient counseling.
Level of evidence: III.
Similar articles
-
Clinical characteristics and prognostic inflection points among long-term survivors of advanced epithelial ovarian cancer.Int J Gynaecol Obstet. 2017 Dec;139(3):352-357. doi: 10.1002/ijgo.12315. Epub 2017 Sep 28. Int J Gynaecol Obstet. 2017. PMID: 28857180
-
Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important?Obstet Gynecol. 2003 Jul;102(1):156-61. doi: 10.1016/s0029-7844(03)00399-5. Obstet Gynecol. 2003. PMID: 12850623
-
Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index.JAMA Oncol. 2015 Sep;1(6):737-45. doi: 10.1001/jamaoncol.2015.1796. JAMA Oncol. 2015. PMID: 26181758 Free PMC article.
-
Who are the long-term survivors of high grade serous ovarian cancer?Gynecol Oncol. 2018 Jan;148(1):204-212. doi: 10.1016/j.ygyno.2017.10.032. Epub 2017 Nov 8. Gynecol Oncol. 2018. PMID: 29128106 Review.
-
[Epithelial ovarian cancer - a change of paradigm].Ther Umsch. 2011 Oct;68(10):565-72. doi: 10.1024/0040-5930/a000215. Ther Umsch. 2011. PMID: 21968896 Review. German.
Cited by
-
Deregulated miR-296/S100A4 axis promotes tumor invasion by inducing epithelial-mesenchymal transition in human ovarian cancer.Am J Cancer Res. 2016 Jan 15;6(2):260-9. eCollection 2016. Am J Cancer Res. 2016. PMID: 27186401 Free PMC article.
-
Impact of Treatment Delay on the Prognosis of Patients with Ovarian Cancer: A Population-based Study Using the Surveillance, Epidemiology, and End Results Database.J Cancer. 2024 Jan 1;15(2):473-483. doi: 10.7150/jca.87881. eCollection 2024. J Cancer. 2024. PMID: 38169558 Free PMC article.
-
The Long-Term Prognostic Significance of Circulating Tumor Cells in Ovarian Cancer-A Study of the OVCAD Consortium.Cancers (Basel). 2021 May 26;13(11):2613. doi: 10.3390/cancers13112613. Cancers (Basel). 2021. PMID: 34073412 Free PMC article.
-
Fast and Durable Intraoperative Near-infrared Imaging of Ovarian Cancer Using Ultrabright Squaraine Fluorophores.Angew Chem Int Ed Engl. 2022 Apr 19;61(17):e202117330. doi: 10.1002/anie.202117330. Epub 2022 Feb 26. Angew Chem Int Ed Engl. 2022. PMID: 35150468 Free PMC article.
-
Next-generation sequencing-based genomic profiling analysis reveals novel mutations for clinical diagnosis in Chinese primary epithelial ovarian cancer patients.J Ovarian Res. 2019 Feb 20;12(1):19. doi: 10.1186/s13048-019-0494-4. J Ovarian Res. 2019. PMID: 30786925 Free PMC article.
References
-
- Howlander N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, et al. SEER Cancer Statistics Review, 1975-2011. Bethesda, MD: National Cancer Institute; 2014. Apr, 2014.
-
- Yost K, Perkins C, Cohen R, Morris C, Wright W. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control. 2001;12:703–11. - PubMed
-
- Chan JK, Cheung MK, Husain A, Teng NN, West D, Whittemore AS, et al. Patterns and progress in ovarian cancer over 14 years. Obstet Gynecol. 2006;108:521–8. - PubMed
-
- Heintz AP, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, et al. Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006;95(Suppl 1):S161–92. - PubMed